Ocular Therapeutix
OCUL
#5706
Rank
NZ$2.35 B
Marketcap
NZ$10.69
Share price
-1.35%
Change (1 day)
-50.40%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -NZ$0.53 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are NZ$52.05 Million. In 2025 the company made an earning of -NZ$0.49 Billion a decrease over its 2024 earnings that were of -NZ$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.53 Billion8.03%
2025 -NZ$0.49 Billion37.43%
2024 -NZ$0.36 Billion139.68%
2023 -NZ$0.15 Billion13.65%
2022 -NZ$0.13 Billion984.05%
2021 -NZ$11.96 Million-95.79%
2020 -NZ$0.29 Billion80.19%
2019 -NZ$0.16 Billion44.01%
2018 -NZ$0.11 Billion-5.38%
2017 -NZ$0.12 Billion41.79%
2016 -NZ$81.56 Million12.47%
2015 -NZ$72.52 Million38.75%
2014 -NZ$52.27 Million115.12%
2013 -NZ$24.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-NZ$20.45 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-NZ$9.35 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-NZ$0.3 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
NZ$0.32 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA